Side effects include:
MenACWY-D (Menactra速): Injection site reactions (e.
g.
, pain, induration, erythema, swelling), headache, fatigue, malaise, arthralgia, diarrhea, anorexia, chills, fever, vomiting, rash.

MenACWY-CRM (Menveo速): Injection site reactions (tenderness, erythema), irritability, sleepiness, persistent crying, change in eating habits, vomiting, diarrhea in infants 2 through 23 months of age; injection site reactions (pain, erythema, induration), irritability, sleepiness, malaise, headache in children 2 through 10 years of age;  injection site pain, headache, myalgia, malaise, nausea in adults and adolescents.

MPSV4 (Menomune速): Injection site reactions (e.
g.
, pain, erythema, induration, swelling), headache, malaise, chills, fever.

Hib-MenCY (MenHibrix速): Injection site reactions (e.
g.
, pain, redness, swelling), systemic effects (e.
g.
, fever, irritability, drowsiness, loss of appetite).

The most common adverse events were injection site pain, headache, irritability, and diarrhea.
Very common (10% or more): Injection site pain (48.
1%), injection site redness (16%), injection site induration (11%), injection site tendernessCommon (1% to 10%): Injection site swelling, injection site hematomaUncommon (0.
1% to 1%): Injection site reactionRare (less than 0.
1%): Severe local reactionsPostmarketing reports: Extensive limb swelling at the injection site (frequently associated with erythema, sometimes involving the adjacent joint or swelling of the entire injected limb)
Very common (10% or more): Headache (41.
8%), drowsiness (11.
2%)Uncommon (0.
1% to 1%): Hypoesthesia, dizzinessVery rare (less than 0.
01%): Somnolence, neurological reactionsPostmarketing reports: Vasovagal syncope, paresthesia, Guillain-Barre syndrome
Very common (10% or more): Fatigue (32.
3%), malaise (22.
3%), feverCommon (1% to 10%): Chills, febrile reactions (>38C)Postmarketing reports: Asthenia, influenza-like symptoms
Very common (10% or more): Irritability (12.
2%)Uncommon (0.
1% to 1%): Insomnia, crying
Very common (10% or more): Arthralgia (16%)Uncommon (0.
1% to 1%): Myalgia, pain in extremityPostmarketing reports: Musculoskeletal stiffness
Very common (10% or more): Appetite lostCommon (1% to 10%): AnorexiaPostmarketing reports: Decreased appetite
Very common (10% or more): Diarrhea (14%)Common (1% to 10%): Vomiting, nausea
Common (1% to 10%): RashUncommon (0.
1% to 1%): PruritusRare (less than 0.
1%): Urticaria, angioedemaPostmarketing reports: Angioneurotic edema
Very common (10% or more): Local axillary lymphadenopathy
Postmarketing reports: Hypersensitivity (such as rash, urticaria, pruritus, dyspnea, angioedema), allergic reactions (including anaphylactic and anaphylactoid reactions)
Uncommon (0.
1% to 1%): Upper respiratory tract illnessRare (less than 0.
1%): Wheeze
Postmarketing reports: IgA nephropathy